INFORMATION FOR
News
Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed:
The Yale Department of Internal Medicine is pleased to highlight the following promotions to professor of medicine.
Kasia Lipska, MD, MHS, was one of five experts invited to testify at the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on December 14, 2023.
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.
A multidisciplinary team of researchers based at Yale will launch a series of studies aimed at accelerating understanding of bipolar disorder and generating new and more effective treatments. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging, will lead the research team.
Providing state-of-the-art clinical care, furthering the understanding of bone disorders, and supporting studies to improve therapies.
A research team led by Hilary Blumberg, MD, director of the Yale Mood Disorders Research Program (MDRP), has been awarded a grant for the study, “A Novel Mitochondrial Target as Therapeutic Approach for Bipolar Disorder.”
Insogna Honored with 2021 Frederic C. Bartter Award
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
Non-communicable diseases are a leading cause of death worldwide. An interdisciplinary group at Yale has joined forces to address these diseases globally.
If you are sending a child off to college who has diabetes, it could be difficult to manage their condition on campus. Dr. Ania Jastreboff, a pediatric endocrinologist with Yale Medicine, tells parents and students how to plan.
Kevan Herold, MD, newly named as C.N.H. Long Professor of Immunobiology and of Medicine, conducts research on the basis for autoimmune diseases and develops new therapies based on these studies. His focus has largely been in the field of autoimmune Type 1 diabetes.
Andrew Goodman, Dr. Kevan Herold, and Dr. Amy Caroline Justice were appointed to C.N.H. Long Professorships.
Researchers say that teplizumab potentially delaying progression to diabetes in patients who are at-risk is important, particularly in children.
Researchers, including those at UPMC Children’s Hospital of Pittsburgh, say they have tested a new drug that for the first time has successfully delayed the onset of Type 1 diabetes in people at risk for developing the disease.
A new drug may delay the onset of insulin-dependent Type 1 diabetes in those who are at high risk for the autoimmune disease, according to the results of a trial published in New England Journal of Medicine.
Connecticut Magazine’s 2019 “Best Doctors” list includes 217 Yale Medicine physicians in 50 specialties who were selected by their peers as the best in their fields.
An investigative therapy has shown capability to delay type 1 diabetes (T1D) progression in patients at high risk of the chronic autoimmune disease.
For the first time, the onset of type 1 diabetes has been successfully delayed in those at high risk using teplizumab, an investigational anti-CD3 monoclonal antibody (Provention Bio).
Those who are most likely to develop type 1 diabetes may be able to stave off the disease for up to 2 years with 2 weeks of treatment with the anti-CD3 antibody teplizumab, according to findings presented at the American Diabetes Association Scientific Sessions.